Caxton Associates (New York)’s Fate Therapeutics FATE Stock Holding History

Caxton Associates (New York)’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$588K	Sell
2024 Q2	$567K	Sell
2024 Q1	$2.13M	Buy
2023 Q3	–	Sell
2023 Q2	$194K	Sell
2023 Q1	$481K	Buy